TMCnet News
39.2% Return Seen to Date on SmarTrend Idenix Pharmaceuticals Call (IDIX)Nov 13, 2012 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified a Downtrend for Idenix Pharmaceuticals (NASDAQ:IDIX) on August 2nd, 2012 at $8.24. In approximately 3 months, Idenix Pharmaceuticals has returned 39.20% as of today's recent price of $5.01. In the past 52 weeks, shares of Idenix Pharmaceuticals have traded between a low of $3.35 and a high of $15.25 and are now at $5.01, which is 50% above that low price. The 200-day and 50-day moving averages have moved 1.82% lower and 3.09% lower over the past week, respectively. Idenix Pharmaceuticals Inc. is a biopharmaceutical company that discovers and develops drugs for the treatment of human viral and other infectious diseases. The Company is focusing on the treatment of infections caused by hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HIV). SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Idenix Pharmaceuticals. Log in and add Idenix Pharmaceuticals (IDIX) to your watchlist today so you can receive a real-time alert when the shares are about to change trend. Write to Chip Brian at [email protected] --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup |